annual CFF:
$191.24M+$116.87M(+157.16%)Summary
- As of today (June 19, 2025), RYTM annual cash flow from financing activities is $191.24 million, with the most recent change of +$116.87 million (+157.16%) on December 31, 2024.
- During the last 3 years, RYTM annual CFF has risen by +$24.76 million (+14.87%).
- RYTM annual CFF is now -10.56% below its all-time high of $213.83 million, reached on December 31, 2022.
Performance
RYTM Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$32.50M-$5.83M(-15.21%)Summary
- As of today (June 19, 2025), RYTM quarterly cash flow from financing activities is $32.50 million, with the most recent change of -$5.83 million (-15.21%) on March 31, 2025.
- Over the past year, RYTM quarterly CFF has increased by +$28.26 million (+665.94%).
- RYTM quarterly CFF is now -80.37% below its all-time high of $165.59 million, reached on March 31, 2021.
Performance
RYTM quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$219.50M+$28.26M(+14.77%)Summary
- As of today (June 19, 2025), RYTM TTM cash flow from financing activities is $219.50 million, with the most recent change of +$28.26 million (+14.77%) on March 31, 2025.
- Over the past year, RYTM TTM CFF has increased by +$140.75 million (+178.75%).
- RYTM TTM CFF is now -29.24% below its all-time high of $310.18 million, reached on June 30, 2018.
Performance
RYTM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RYTM Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +157.2% | +665.9% | +178.8% |
| 3 y3 years | +14.9% | +8045.1% | +10000.0% |
| 5 y5 years | +17.0% | +4496.8% | +34.0% |
RYTM Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.6% | +157.2% | -79.5% | +3467.8% | -2.8% | >+9999.0% |
| 5 y | 5-year | -10.6% | +9419.3% | -80.4% | +3467.8% | -2.8% | >+9999.0% |
| alltime | all time | -10.6% | >+9999.0% | -80.4% | +3467.8% | -29.2% | >+9999.0% |
RYTM Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $32.50M(-15.2%) | $219.50M(+14.8%) |
| Dec 2024 | $191.24M(+157.2%) | $38.33M(+1438.0%) | $191.24M(+23.1%) |
| Sep 2024 | - | $2.49M(-98.3%) | $155.34M(-31.2%) |
| Jun 2024 | - | $146.18M(+3345.2%) | $225.89M(+186.9%) |
| Mar 2024 | - | $4.24M(+75.1%) | $78.74M(+5.9%) |
| Dec 2023 | $74.37M(-65.2%) | $2.42M(-96.7%) | $74.37M(-16.7%) |
| Sep 2023 | - | $73.04M(-7669.2%) | $89.31M(-48.9%) |
| Jun 2023 | - | -$965.00K(+625.6%) | $174.83M(-18.0%) |
| Mar 2023 | - | -$133.00K(-100.8%) | $213.30M(-0.2%) |
| Dec 2022 | $213.83M(+28.4%) | $17.36M(-89.0%) | $213.83M(+8.8%) |
| Sep 2022 | - | $158.56M(+322.8%) | $196.56M(+411.7%) |
| Jun 2022 | - | $37.50M(+9298.5%) | $38.41M(+2866.2%) |
| Mar 2022 | - | $399.00K(+299.0%) | $1.29M(-99.2%) |
| Dec 2021 | $166.48M(+8186.8%) | $100.00K(-75.8%) | $166.48M(-0.2%) |
| Sep 2021 | - | $413.00K(+7.8%) | $166.80M(-0.2%) |
| Jun 2021 | - | $383.00K(-99.8%) | $167.09M(+0.1%) |
| Mar 2021 | - | $165.59M(>+9900.0%) | $166.89M(+8207.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $2.01M(-98.8%) | $420.00K(-39.9%) | $2.01M(-98.8%) |
| Sep 2020 | - | $699.00K(+282.0%) | $163.55M(+0.0%) |
| Jun 2020 | - | $183.00K(-74.1%) | $163.55M(-0.2%) |
| Mar 2020 | - | $707.00K(-99.6%) | $163.87M(+0.2%) |
| Dec 2019 | $163.47M(-0.7%) | $161.96M(>+9900.0%) | $163.47M(+9724.2%) |
| Sep 2019 | - | $697.00K(+40.0%) | $1.66M(-22.2%) |
| Jun 2019 | - | $498.00K(+57.6%) | $2.14M(-98.7%) |
| Mar 2019 | - | $316.00K(+106.5%) | $165.00M(+0.2%) |
| Dec 2018 | $164.69M(-1.5%) | $153.00K(-87.0%) | $164.69M(-43.2%) |
| Sep 2018 | - | $1.17M(-99.3%) | $290.19M(-6.4%) |
| Jun 2018 | - | $163.36M(>+9900.0%) | $310.18M(+111.3%) |
| Mar 2018 | - | $0.00(-100.0%) | $146.82M(-12.2%) |
| Dec 2017 | $167.20M(>+9900.0%) | $125.66M(+493.7%) | $167.20M(+302.5%) |
| Sep 2017 | - | $21.16M(>+9900.0%) | $41.54M(+103.9%) |
| Jun 2017 | - | $0.00(-100.0%) | $20.38M(0.0%) |
| Mar 2017 | - | $20.38M | $20.38M |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | $41.71M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFF year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of RYTM is $191.24M
What is the all time high annual CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from financing activities is $213.83M
What is Rhythm Pharmaceuticals annual CFF year-on-year change?
Over the past year, RYTM annual cash flow from financing activities has changed by +$116.87M (+157.16%)
What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of RYTM is $32.50M
What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from financing activities is $165.59M
What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, RYTM quarterly cash flow from financing activities has changed by +$28.26M (+665.94%)
What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of RYTM is $219.50M
What is the all time high TTM CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from financing activities is $310.18M
What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
Over the past year, RYTM TTM cash flow from financing activities has changed by +$140.75M (+178.75%)